I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| natural killer cell | 6 studies | 19% ± 3% | |
| epithelial cell | 5 studies | 33% ± 9% | |
| goblet cell | 4 studies | 16% ± 1% | |
| hematopoietic precursor cell | 3 studies | 20% ± 3% | |
| non-classical monocyte | 3 studies | 22% ± 4% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 20% ± 1% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 20% ± 3% | |
| dendritic cell | 3 studies | 26% ± 6% | |
| erythrocyte | 3 studies | 33% ± 11% | |
| plasmacytoid dendritic cell | 3 studies | 20% ± 2% | |
| gamma-delta T cell | 3 studies | 22% ± 7% | |
| regulatory T cell | 3 studies | 17% ± 1% |
